Abnormal interleukin-7 function in common variable immunodeficiency

Are Martin Holm1, Pål Aukrust, Jan Kristian Damås

  • 1Section of Clinical Immunology and Infectious Diseases, Medical Center, Oslo, Norway. a.m.holm@klinmed.uio.no

Blood
|December 16, 2004
PubMed

Insights

Common variable immunodeficiency (CVID) involves low immunoglobulin levels and frequent infections. This study found elevated Interleukin-7 (IL-7) in some CVID patients, suggesting new insights into disease mechanisms.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinemia, leading to recurrent infections.
  • T-cell abnormalities are frequently observed in CVID patients.
  • Interleukin-7 (IL-7) plays a crucial role in lymphocyte homeostasis and has been implicated in lymphopenic conditions.

Purpose of the Study:

  • To investigate the role of Interleukin-7 (IL-7) in a subgroup of patients with Common variable immunodeficiency (CVID).
  • To explore potential novel pathogenic mechanisms and identify therapeutic targets in CVID.

Main Methods:

  • Measurement of plasma Interleukin-7 (IL-7) levels in CVID patients.
  • Analysis of circulating T-cell populations, including CD8+ T cells, apoptosis rates, and effector-memory T cell subsets (CCR7-).
  • In vitro assessment of T-cell response to IL-7, including proliferation and cytokine secretion (interferon gamma, transforming growth factor beta).

Main Results:

  • Elevated plasma levels of circulating Interleukin-7 (IL-7) were identified in a subgroup of CVID patients.
  • These patients exhibited increased numbers of circulating CD8+ T cells with reduced apoptosis.
  • A predominance of CC chemokine receptor 7- (CCR7-) effector-memory T cells and impaired in vitro response to IL-7 were observed in some patients.

Conclusions:

  • Elevated IL-7 levels and specific T-cell abnormalities characterize a subset of CVID patients.
  • These findings suggest novel pathogenic pathways contributing to CVID.
  • The study highlights IL-7 and associated T-cell dysregulation as potential targets for future CVID research and therapeutic strategies.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...